Dr. Reddy's Laboratories, Inc. Acquires 9.7% Stake in Coya Therapeutics, Inc.

Dr. Reddy's Laboratories, Inc., along with its parent companies Dr. Reddy's Laboratories SA and Dr. Reddy's Laboratories Limited, has acquired a beneficial ownership of 2,272,727 shares of Coya Therapeutics, Inc. Common Stock. This represents a 9.7% ownership stake in the company. The acquisition was reported on a Schedule 13G filing dated March 12, 2026, with an event date of January 30, 2026. Dr. Reddy's Laboratories, Inc. holds sole voting and dispositive power over these shares. The filing includes certifications that the securities were not acquired or held for the purpose of changing or influencing the control of the issuer.